Products
Latest Partnered Companies
Projects
Estimated Cost :
$10 million
SCA Pharma Invests $10 million to Build a New Production Facility in Little Rock
SCA Pharma announced its plans to expand operations with the construction of a new production facility in Little Rock
Estimated Cost :
$19 million
Summit Biosciences to invest $19 million in it's production at Lexington, Kentucky
Summit Biosciences Inc., a pharmaceutical company focused on nasal spray medicines, is expanding its operation at the University of Kentucky Coldstrea...
Estimated Cost :
€25 million
Evonik Expands Dossenheim and Hanau Sites in Germany
Evonik has announced plans for the expansion of its Dossenheim and Hanau facilities in Germany in order to meet the increasing pharmaceutical demand f...
Estimated Cost :
-
FUJIFILM Diosynth Biotechnologies to Construct New Biocampus in UK
FUJIFILM Diosynth Biotechnologies (FDB)unveiled its plans for the construction of a new BioCampus
Press Release
Abveris Announces Equity-Bearing Antibody Discovery Partnership with Saccharo
Abveris, Inc. ("Abveris") announced that it has entered into an antibody discovery partnership with Saccharo, Inc. ("Saccharo") for the discovery of monoclonal antibodies to advance the Saccharo therapeutic pipeline. Under the terms of the agreement, Abveris will utilize its proprietary DiversimAbTM mouse model in combination
Tilray, Inc. and Hormosan sign cooperation agreement to commercialize medicinal cannabis extracts in Germany
Tilray, Inc., a leader in the manufacture, research, and distribution of medical cannabis, has a Agreement reached for the joint marketing of its full-spectrum cannabis extracts in Germany from January 1, 2021.
Kindeva and BOL Pharma Sign Agreement for Development of Inhaled Cannabinoid Products
Kindeva Drug Delivery (Kindeva) and Breath of Life International (BOL Pharma or BOL) have signed an agreement to study the feasibility of multiple inhaled cannabinoid products. Under the agreement, Kindeva will develop novel formulations of BOL Pharma’s cannabinoid-based drug products delivered by Kindeva’s metered-dose inhaler (MDI) technology.
Sesen Bio Announces Partnership with Hikma Pharmaceuticals for the Commercialization of Vicineum™ in the Middle East and North Africa
Sesen Bio, a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and Hikma Pharmaceuticals, a multi-national pharmaceutical company and leading licensing partner in the Middle East and North Africa (“MENA”) region specializing in the development and commercialization of a broad range of high-quality medicines
Events
Global Conference on Pharma and Pharmaceutical Sciences 2020
2nd European Congress on Nanomedicine and Drug Delivery System
Articles
Nanotechnology in Drug Delivery to Eyes, Skin, and Wounds Via Topical Route
One of the most favored courses for administering medications to eyes, skin, and wounds is the topical route. The principle objective for this
An Overview - Active Pharmaceutical Ingredient (API)
Active Pharmaceutical Ingredient (API) is the term used to refer to the biologically active component of a drug product
Next-Generation Biological Therapeutics Discovery & Development
Next-Generation Biological Therapeutics Discovery & Development
AI, Big Data to Have \'Greatest Technology Impact\' in Pharma Industry in 2019
AI, Big Data to Have \'Greatest Technology Impact\' in Pharma Industry in 2019
Dividella’s Monomaterial Packaging Solution to the Global Plastics Crisis
Dividella’s Monomaterial Packaging Solution to the Global Plastics Crisis
Expert Talk
Testimonials
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
Advertisements
See your banner here...
